IN2014DE03239A - - Google Patents
Info
- Publication number
- IN2014DE03239A IN2014DE03239A IN3239DE2014A IN2014DE03239A IN 2014DE03239 A IN2014DE03239 A IN 2014DE03239A IN 3239DE2014 A IN3239DE2014 A IN 3239DE2014A IN 2014DE03239 A IN2014DE03239 A IN 2014DE03239A
- Authority
- IN
- India
- Prior art keywords
- mannitol
- weight
- granulated composite
- sorbitol
- degree
- Prior art date
Links
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 12
- 235000010355 mannitol Nutrition 0.000 abstract 6
- 239000002131 composite material Substances 0.000 abstract 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 2
- 239000006185 dispersion Substances 0.000 abstract 2
- -1 hydroxypropoxy Chemical group 0.000 abstract 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 abstract 2
- 229960002920 sorbitol Drugs 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013237000 | 2013-11-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DE03239A true IN2014DE03239A (enExample) | 2015-07-17 |
Family
ID=51951602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3239DE2014 IN2014DE03239A (enExample) | 2013-11-15 | 2014-11-10 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20150141517A1 (enExample) |
| EP (1) | EP2873415B1 (enExample) |
| JP (1) | JP6307417B2 (enExample) |
| KR (1) | KR102253849B1 (enExample) |
| CN (1) | CN104644581A (enExample) |
| IN (1) | IN2014DE03239A (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016098459A1 (ja) * | 2014-12-17 | 2016-06-23 | 株式会社ダイセル | 遅延崩壊性粒子組成物 |
| US12178814B2 (en) | 2019-04-03 | 2024-12-31 | Astellas Pharma Inc. | Pharmaceutical composition |
| US20230149313A1 (en) * | 2020-04-10 | 2023-05-18 | Japan Vam & Poval Co., Ltd. | Sustained-release base |
| EP4134103A4 (en) * | 2020-04-10 | 2024-04-24 | Japan Vam & Poval Co., Ltd. | BINDER |
| WO2022020585A1 (en) | 2020-07-24 | 2022-01-27 | Elanco Us Inc. | Process for making an isoxazoline compound and intermediate thereof |
| JP7414668B2 (ja) * | 2020-08-28 | 2024-01-16 | 信越化学工業株式会社 | ポリビニルアルコール含有造粒物及び固形製剤 |
| JP7590950B2 (ja) * | 2020-12-18 | 2024-11-27 | 大鵬薬品工業株式会社 | ビラスチンを含有する口腔内崩壊錠 |
| KR20230146800A (ko) | 2022-04-13 | 2023-10-20 | 주식회사 산흥이지 | 도로교통 표지판의 각도 조절장치 |
| CN116510026B (zh) * | 2023-07-04 | 2023-09-19 | 山东天力药业有限公司 | 一种甘露醇复合药用辅料及其制备方法 |
| WO2025078588A1 (en) * | 2023-10-12 | 2025-04-17 | Dfe Pharma Gmbh & Co. Kg | Method and system for preparing agglomerated excipient granules |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3864406A (en) * | 1973-04-25 | 1975-02-04 | Suomen Sokeri Oy | Process for the production of mannitol and sorbitol |
| PT1260215E (pt) * | 2000-03-01 | 2009-09-03 | Eisai R&D Man Co Ltd | Comprimido de desintegração rápida que contém poli(álcool vinílico) |
| JP3595765B2 (ja) * | 2000-09-27 | 2004-12-02 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤 |
| JP4279220B2 (ja) * | 2004-09-09 | 2009-06-17 | 日信工業株式会社 | 複合材料及びその製造方法、複合金属材料及びその製造方法 |
| TWI383809B (zh) * | 2005-06-29 | 2013-02-01 | Otsuka Pharma Co Ltd | 含有西洛他唑（ｃｉｌｏｓｔａｚｏｌ）之口腔崩解粉末 |
| CN102223880B (zh) * | 2008-11-25 | 2017-04-26 | 田边三菱制药株式会社 | 口腔速崩片及其制备方法 |
| JP5753661B2 (ja) | 2009-01-26 | 2015-07-22 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロース水分散液を用いた湿式造粒打錠法 |
| EP2465495A4 (en) * | 2009-08-11 | 2013-01-23 | Dainippon Sumitomo Pharma Co | TABLET WITH FAST DECOMPOSITION IN THE MOUTH AND TWO OR MORE TYPES OF PARTICLES |
| JP6073543B2 (ja) * | 2010-07-08 | 2017-02-01 | 沢井製薬株式会社 | ロラタジン含有口腔内崩壊錠の製造方法 |
| WO2012091049A1 (ja) * | 2010-12-28 | 2012-07-05 | 大鵬薬品工業株式会社 | 口腔内崩壊錠剤 |
| JP2012236823A (ja) * | 2011-04-28 | 2012-12-06 | Fuji Chem Ind Co Ltd | 耐湿安定性に優れた錠剤 |
| EP2768487B1 (en) * | 2011-10-21 | 2020-06-03 | Zinfandel Pharmaceuticals, Inc. | Sustained-release preparation |
| WO2013098576A1 (en) * | 2011-12-31 | 2013-07-04 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Immediate release pharmaceutical composition of valsartan |
| EP2674149B1 (en) * | 2012-06-15 | 2017-10-04 | Shin-Etsu Chemical Co., Ltd. | Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation |
-
2014
- 2014-11-06 US US14/534,337 patent/US20150141517A1/en not_active Abandoned
- 2014-11-10 IN IN3239DE2014 patent/IN2014DE03239A/en unknown
- 2014-11-12 KR KR1020140157082A patent/KR102253849B1/ko active Active
- 2014-11-12 EP EP14192872.1A patent/EP2873415B1/en active Active
- 2014-11-14 CN CN201410648049.8A patent/CN104644581A/zh active Pending
- 2014-11-14 JP JP2014231521A patent/JP6307417B2/ja active Active
-
2019
- 2019-10-14 US US16/601,270 patent/US11723872B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2873415A1 (en) | 2015-05-20 |
| JP2015117240A (ja) | 2015-06-25 |
| CN104644581A (zh) | 2015-05-27 |
| KR102253849B1 (ko) | 2021-05-21 |
| KR20150056474A (ko) | 2015-05-26 |
| US20200038333A1 (en) | 2020-02-06 |
| JP6307417B2 (ja) | 2018-04-04 |
| US20150141517A1 (en) | 2015-05-21 |
| US11723872B2 (en) | 2023-08-15 |
| EP2873415B1 (en) | 2018-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DE03239A (enExample) | ||
| MX2013007057A (es) | Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos. | |
| MX2015017036A (es) | Metodo para producir celulas progenitoras renales y farmaco que comprende las mismas. | |
| MX2015008427A (es) | Proceso de granulacion en seco para producir composiciones de comprimidos de metformina y sus composiciones. | |
| MY187637A (en) | Composite formulation for oral administration comprising ezetimibe and rosuvastatin | |
| MA44637B1 (fr) | Composes hétérocycliques et leurs utilisations | |
| EA201391053A1 (ru) | Таблетка, диспергируемая в ротовой полости | |
| MX2020012596A (es) | Procesos e intermedios para preparar un medicamento. | |
| PH12016500043A1 (en) | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-andrenergic for administration by inhalation | |
| HK1232218A1 (zh) | Cgrp-活性化合物的片剂制剂 | |
| WO2014114255A3 (zh) | 一种定位速释生物粘附剂及应用 | |
| MX390947B (es) | Composiciones terapéuticas de ceramidasa ácida y métodos para prepararlas y utilizarlas. | |
| HK1214519A1 (zh) | 雙用途硫酸鹽口服藥物組合物片劑及其使用方法 | |
| NZ628451A (en) | Dehydrated plant-derived products and methods for making the same | |
| MX2016008527A (es) | Preparaciones solidas que contienen tofogliflozina y proceso para producir las mismas. | |
| WO2014006636A3 (en) | Stable compositions of fesoterodine | |
| AU2013338098A8 (en) | Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof | |
| WO2014108918A3 (en) | Injectable antifungal formulation | |
| TW201613620A (en) | Jelly-like medicinal composition of potassium iodide | |
| MY182080A (en) | Method for manufacturing thickener composition | |
| PH12014502170A1 (en) | Drug composition and soft capsule drug sealing the drug composition | |
| EP3050575A4 (en) | Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition | |
| UA115995C2 (uk) | Двошаровий композиційний таблетований склад, що містить аторвастатин, ірбесартан і карбонат магнію | |
| IN2012CH03125A (enExample) | ||
| RU2013125067A (ru) | Способ биоинкапсуляции бетаина, обладающего супрамолекулярными свойствами |